← The record

Amino Acid Formula With Carbohydrate Without Phenylalanine

Recommended MetabolicRestrictedNot applicable line 💬 consumer voice

Dietary management of phenylketonuria (PKU).

1
Submissions
2019–19
On the record
ICER range
Cost-min
Cost basis

Decision on record

1 decision
  • Meeting Nov 2019 Recommended Phenylketonuria (PKU)

Access path

1 submission · public record
  1. Nov 2019
    Recommended

    vs Phlexy-10 tablets

  2. PBS listing · Restricted
RecommendedDeferredNot recommended

From the public summary

Verbatim · PSD text · may span indications
PBAC outcome
7.1 The PBAC recommended the Restricted Benefit listing of amino acid formula with carbohydrate without phenylalanine, PKU Easy Tablet®, for the dietary management of phenylketonuria (PKU).PSD · Nov 2019
7.2 The PBAC noted the Nutritional Products Working Party (NPWP) supported the proposed listing as a treatment option for the dietary management of PKU. The PBAC also noted the NPWP advice that PKU Easy does not contain any vitamins, minerals or trace elements, and that patients would therefore have to meet their dietary needs through other sources, which may include use of PBS-subsidised vitamin, mineral and trace element supplements such as Phlexy-vits …PSD · Nov 2019
Consumer comments
5.4 The minor submission stated that an additional source of vitamins, minerals and trace elements would be required for patients using PKU Easy to ensure adequate nutrient intake. 2PSD · Nov 2019

Cost-effectiveness

Cost-minimisation analysis; no ICER calculated. Pricing based on cost equivalence per gram of protein equivalent to comparator.

On balance, the PBAC considered that PKU Easy was a suitable alternative amino acid formula for some patients and would be acceptably cost-effective if it costs no more per gram of protein than the cheapest alternative amino acid formula currently available for PKU. PBAC · 2019
Price cut / RSA neededCost-effectiveness accepted

Decision context

PopulationPatients with phenylketonuria (PKU) requiring dietary management with an amino acid formula without phenylalanine.

Submission history

1 entries
DecidedOutcomeComparatorICEREvidence
Nov 2019 Recommended Phlexy-10 tablets Cost-minimisation · Cost-minimisation

Consumer voice

Nov 2019

No consumer comments were received for this item.

The PBAC noted that no consumer comments were received for this item. Consumer comments · PSD

Similar precedents

By decision profile